• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Empagliflozin improves clinical outcomes for HFpEF in EMPEROR-Preserved.

作者信息

Huynh Karina

机构信息

Nature Reviews Cardiology, .

出版信息

Nat Rev Cardiol. 2021 Nov;18(11):737. doi: 10.1038/s41569-021-00627-z.

DOI:10.1038/s41569-021-00627-z
PMID:34526679
Abstract
摘要

相似文献

1
Empagliflozin improves clinical outcomes for HFpEF in EMPEROR-Preserved.恩格列净在EMPEROR-Preserved研究中改善了射血分数保留的心力衰竭（HFpEF）的临床结局。
Nat Rev Cardiol. 2021 Nov;18(11):737. doi: 10.1038/s41569-021-00627-z.
2
Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial.恩格列净对射血分数保留的慢性心力衰竭患者发病率和死亡率影响的评估：EMPEROR-Preserved 试验的原理和设计。
Eur J Heart Fail. 2019 Oct;21(10):1279-1287. doi: 10.1002/ejhf.1596. Epub 2019 Sep 16.
3
Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial.在 EMPEROR-Preserved 试验中射血分数保留型心力衰竭患者的基线特征。
Eur J Heart Fail. 2020 Dec;22(12):2383-2392. doi: 10.1002/ejhf.2064.
4
Early benefit with empagliflozin in heart failure with preserved ejection fraction: insights from the EMPEROR-Preserved trial.恩格列净对射血分数保留的心力衰竭的早期获益：来自EMPEROR-Preserved试验的见解
Eur J Heart Fail. 2022 Feb;24(2):245-248. doi: 10.1002/ejhf.2420. Epub 2022 Jan 18.
5
Empagliflozin in Black Versus White Patients With Heart Failure: Analysis of EMPEROR-Pooled.恩格列净在黑人与白人心力衰竭患者中的应用：EMPEROR汇总分析
Circulation. 2023 Jan 3;147(1):101-104. doi: 10.1161/CIRCULATIONAHA.122.062644. Epub 2022 Nov 7.
6
Letter by Gronda et al Regarding Article, "Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial".格伦达等人就文章《恩格列净对射血分数保留的心力衰竭患者心力衰竭事件恶化的影响：EMPEROR-Preserved试验》的来信
Circulation. 2022 Apr 19;145(16):e839-e840. doi: 10.1161/CIRCULATIONAHA.121.057530. Epub 2022 Apr 18.
7
Evidence for empagliflozin in heart failure with preserved ejection fraction (HFpEF).恩格列净在射血分数保留型心力衰竭（HFpEF）中的证据。
Drug Ther Bull. 2023 Feb;61(2):22-23. doi: 10.1136/dtb.2022.000060. Epub 2022 Dec 12.
8
[Empagliflozin in the treatment of heart failure with preserved ejection fraction].
Inn Med (Heidelb). 2022 Jul;63(7):808-810. doi: 10.1007/s00108-022-01345-5. Epub 2022 May 17.
9
Empagliflozin Improves Quality of Life in HFpEF.恩格列净改善射血分数保留的心力衰竭患者的生活质量。
JAMA. 2022 Apr 26;327(16):1539. doi: 10.1001/jama.2022.4950.
10
SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials.钠-葡萄糖协同转运蛋白 2 抑制剂在射血分数降低的心力衰竭患者中的应用：EMPEROR-Reduced 和 DAPA-HF 试验的荟萃分析。
Lancet. 2020 Sep 19;396(10254):819-829. doi: 10.1016/S0140-6736(20)31824-9. Epub 2020 Aug 30.

引用本文的文献

1
Potential of Sodium-Glucose Cotransporter-2 Inhibitors in the Management of Heart Failure With Preserved Ejection Fraction: A Narrative Review.钠-葡萄糖协同转运蛋白2抑制剂在射血分数保留的心力衰竭管理中的潜力：一项叙述性综述
Cureus. 2024 Nov 18;16(11):e73906. doi: 10.7759/cureus.73906. eCollection 2024 Nov.
2
Targeting epicardial adipose tissue: A potential therapeutic strategy for heart failure with preserved ejection fraction with type 2 diabetes mellitus.靶向心外膜脂肪组织：射血分数保留的心力衰竭合并2型糖尿病的一种潜在治疗策略。
World J Diabetes. 2023 Jun 15;14(6):724-740. doi: 10.4239/wjd.v14.i6.724.
3
Sodium-glucose cotransporter 2 inhibitor may not prevent atrial fibrillation in patients with heart failure: a systematic review.

本文引用的文献

1
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial.恩格列净对射血分数保留的心力衰竭患者心力衰竭恶化事件的影响：EMPEROR-Preserved 试验。
Circulation. 2021 Oct 19;144(16):1284-1294. doi: 10.1161/CIRCULATIONAHA.121.056824. Epub 2021 Aug 29.
2
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.恩格列净治疗射血分数保留的心力衰竭。
N Engl J Med. 2021 Oct 14;385(16):1451-1461. doi: 10.1056/NEJMoa2107038. Epub 2021 Aug 27.
钠-葡萄糖共转运蛋白 2 抑制剂可能无法预防心力衰竭患者的心房颤动：系统评价。
Cardiovasc Diabetol. 2023 May 24;22(1):124. doi: 10.1186/s12933-023-01860-1.